|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
INSM | Flammer Martina M.D. | Chief Medical Officer | Jan 12 | Sale | 28.63 | 4,667 | 133,616 | 106,898 | Jan 12 04:06 PM |
INSM | Flammer Martina M.D. | Chief Medical Officer | Jan 09 | Sale | 29.01 | 4,715 | 136,782 | 112,810 | Jan 11 04:08 PM |
INSM | Flammer Martina M.D. | Chief Medical Officer | Jan 10 | Sale | 28.90 | 1,245 | 35,980 | 111,565 | Jan 11 04:08 PM |
INSM | Flammer Martina M.D. | Chief Medical Officer | Jan 05 | Sale | 29.20 | 1,386 | 40,478 | 117,525 | Jan 05 05:29 PM |
INSM | Flammer Martina M.D. | Chief Medical Officer | Dec 22 | Option Exercise | 23.66 | 28,310 | 669,815 | 134,348 | Dec 22 04:04 PM |
INSM | Flammer Martina M.D. | Chief Medical Officer | Dec 22 | Sale | 30.00 | 28,310 | 849,300 | 106,038 | Dec 22 04:04 PM |
INSM | Flammer Martina M.D. | Chief Medical Officer | Jun 13 | Sale | 19.27 | 8,868 | 170,886 | 106,038 | Jun 15 04:06 PM |
INSM | Flammer Martina M.D. | Chief Medical Officer | May 15 | Sale | 19.28 | 2,576 | 49,665 | 116,624 | May 17 04:10 PM |
INSM | Flammer Martina M.D. | Chief Medical Officer | May 16 | Sale | 18.43 | 1,718 | 31,663 | 114,906 | May 17 04:10 PM |
INSM | Flammer Martina M.D. | Chief Medical Officer | Jan 10 | Sale | 18.06 | 3,439 | 62,108 | 72,763 | Jan 12 04:09 PM |
INSM | Flammer Martina M.D. | Chief Medical Officer | Jan 05 | Sale | 19.73 | 1,374 | 27,109 | 65,058 | Jan 06 04:22 PM |
INSM | Flammer Martina M.D. | Chief Medical Officer | May 16 | Sale | 18.51 | 1,574 | 29,135 | 66,432 | May 18 04:07 PM |
INSM | Flammer Martina M.D. | Chief Medical Officer | Jan 11 | Sale | 25.11 | 1,495 | 37,539 | 46,038 | Jan 13 04:41 PM |
INSM | Flammer Martina M.D. | Chief Medical Officer | Jan 05 | Sale | 27.61 | 1,423 | 39,289 | 33,345 | Jan 07 04:23 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite